Probi AB is an international company that focuses on developing, producing, and delivering clinically proven probiotics. It operates through the following geographical segments: Americas (North and South America), EMEA (Europe, Middle East and Africa), and APAC (Asia and the Pacific). The company was founded in 1991 and is headquartered in Lund, Sweden.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company